0001437749-15-005862.txt : 20150323 0001437749-15-005862.hdr.sgml : 20150323 20150323201725 ACCESSION NUMBER: 0001437749-15-005862 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150319 FILED AS OF DATE: 20150323 DATE AS OF CHANGE: 20150323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RESPONSE BIOMEDICAL CORP CENTRAL INDEX KEY: 0000806888 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1781 - 75TH AVENUE W. CITY: VANCOUVER STATE: A1 ZIP: V6P6P2 BUSINESS PHONE: 604-456-6010 MAIL ADDRESS: STREET 1: 1781 - 75TH AVENUE W. CITY: VANCOUVER STATE: A1 ZIP: V6P6P2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shuster Lewis CENTRAL INDEX KEY: 0001471131 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50571 FILM NUMBER: 15720278 MAIL ADDRESS: STREET 1: 421 BRIDOON TERRACE CITY: ENCINITAS STATE: CA ZIP: 92024 4 1 rdgdoc.xml FORM 4 X0306 4 2015-03-19 0000806888 RESPONSE BIOMEDICAL CORP RBM 0001471131 Shuster Lewis 1781 - 75TH AVENUE W. VANCOUVER A1 V6P 6P2 BRITISH COLUMBIA, CANADA 1 Common Stock 2015-03-19 4 A 0 9510 0 D 57852 D Stock Option (Right to Buy) 0.92 2015-03-19 4 A 0 5000 0 A 2025-03-19 Common Stock 5000 5000 D 100% of the restricted share units vested on the date of grant. The expiration date for each of the restricted share units will be the earlier of three (3) years after the effective date or two (2) years following the grantee's termination date. The reporting person has elected to defer receipt of the common stock underlying the restricted share units until a later date not to exceed the expiration date. Exercise prices shown are denominated in Canadian dollars. 100% of the options vest on March 20, 2016, subject to the reporting person's continued service as a director of the Company through each vesting date. /s/ Anastasios Tsonis, Attorney in Fact 2015-03-23